| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| mesalazine 500 mg modified release granules, sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| Salofalk 1.5 g modified release granules, 1.5 g sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| Salofalk 1 g modified release granules, sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| Salofalk (mesalazine 3 g) modified release granules, 3 g sachet (trade product unit of use) |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| mesalazine 1.5 g modified release granules, sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| Salofalk 500 mg modified release granules, 500 mg sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| mesalazine 3 g modified release granules, sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| para-aminosalicylic acid 4 g modified release granules, sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| Paser 4 g modified release granules, 4 g sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| Pentasa 2 g modified release granules, 2 g sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| morphine sulfate pentahydrate 60 mg modified release granules, 1 sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| morphine sulfate pentahydrate 20 mg modified release granules, 1 sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| morphine sulfate pentahydrate 100 mg modified release granules, 1 sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| morphine sulfate pentahydrate 30 mg modified release granules, 1 sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| morphine sulfate pentahydrate 200 mg modified release granules, 1 sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| mesalazine 2 g modified release granules, sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| mesalazine 1 g modified release granules, sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| MS Contin Suspension 200 mg modified release granules, 1 sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| Pentasa 1 g modified release granules, sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| MS Contin Suspension 30 mg modified release granules, 1 sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| MS Contin Suspension 100 mg modified release granules, 1 sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| MS Contin Suspension 20 mg modified release granules, 1 sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| MS Contin Suspension 60 mg modified release granules, 1 sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| mesalazine 4 g modified release granules, sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|
| Pentasa 4 g modified release granules, 4 g sachet |
has manufactured dose form |
True |
modified release granules |
Inferred relationship |
Some |
|